financetom
Business
financetom
/
Business
/
BMO Previews Canadian Banks' Q3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO Previews Canadian Banks' Q3
Aug 25, 2025 10:36 AM

01:28 PM EDT, 08/25/2025 (MT Newswires) -- Canadian banks report their third-quarter results from August 26, with Scotiabank (BNS.TO), and BMO (BMO.TO), notes BMO.

Across the "Big 5" (excluding BMO) analysts Sohrab Movahedi and Etienne Ricard expect cash operating EPS to be essentially flat y/y, with growth slowing relative to the first half of 2025.

"Our estimates contemplate high-single-digit y/y PTPP industry earnings growth, with higher y/y NIM and mid-single-digit fee revenue growth offsetting muted loan growth; we expect sequentially lower performing PCL builds but still higher total PCL ratios y/y."

While the analysts are maintaining their "best offense is a good defense" stance, they say they have a more optimistic earnings outlook for banks beyond the third quarter, which is predicated on a stronger macroeconomic backdrop in Canada.

Movahedi's and Ricard's preferred names have greater exposure to the Canadian market (higher ROE). They recommend Outperform-rated CIBC (CM.TO), National Bank (NA.TO) and RBC (RY.TO).

Price: 158.31, Change: -0.37, Percent Change: -0.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
Apr 22, 2024
On Monday, Eli Lilly and Company ( LLY )  agreed to acquire a manufacturing facility from Nexus Pharmaceuticals. The deal terms were not disclosed. The acquisition of this FDA-approved facility in Pleasant Prairie, Wisconsin, will further expand Lilly’s global parenteral (injectable) product manufacturing network and support increased demand for the company’s medicines.  Related: Novo Nordisk/Eli Lilly’s Weight Loss Drugs Does Not Cause Suicidal Behaviors – After...
Update: Market Chatter: Jana Urges Wolfspeed to Explore Sale, Other Options
Update: Market Chatter: Jana Urges Wolfspeed to Explore Sale, Other Options
Apr 22, 2024
02:16 PM EDT, 04/22/2024 (MT Newswires) -- (Updates with additional information.) Activist investor Jana Partners urged Wolfspeed ( WOLF ) to explore ways to improve shareholder value, including a potential sale, Reuters reported Monday citing a letter it reviewed. The letter reportedly said that Goldman Sachs had assigned a $126 per share M&A price target to the company. Jana Partners...
Netflix Shatters Earnings Expectations With Surprising Revenue Reveal And Soaring Subscriber Surge - But What's Happening With The Stock?
Netflix Shatters Earnings Expectations With Surprising Revenue Reveal And Soaring Subscriber Surge - But What's Happening With The Stock?
Apr 22, 2024
Netflix ( NFLX )'s first-quarter earnings exceeded expectations with a revenue of $9.4 billion. After rallying 234% from a May 2022 low of $164, Netflix ( NFLX )'s stock has shown significant volatility, with investors closely monitoring the $500 support level. In its first-quarter earnings report, Netflix Inc ( NFLX ) has surpassed all expectations, revealing a revenue of $9.4...
Cherry Hill Mortgage Investment to Explore Strategic Options
Cherry Hill Mortgage Investment to Explore Strategic Options
Apr 22, 2024
02:23 PM EDT, 04/22/2024 (MT Newswires) -- Cherry Hill Mortgage Investment ( CHMI ) said Monday its board has formed a special committee to explore strategic options, including a merger or sale, to maximize shareholder value. There can be no assurance that this will lead to any transaction, the company said. Shares of the company were up nearly 7% in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved